NCT03528967View on ClinicalTrials.gov

Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women

PHASE4CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

October 23, 2013

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Placental InsufficiencyEnoxaparin
Interventions
DRUG

Enoxaparin 40 mg / 0.4 mL Prefilled Syringe

DRUG

Aspirin 100 mg Oral Tablet, Enteric Coated

Trial Locations (1)

Unknown

Maternity Center of Wassila Bourguiba Hospital - Department A, Tunis

All Listed Sponsors
lead

Les Laboratoires des Médicaments Stériles

INDUSTRY

NCT03528967 - Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women | Biotech Hunter | Biotech Hunter